The bill adds two new sections to Substitute Senate Bill 6094. Section 1 contains legislative findings about infants born exposed to various substances, the needs of substance-exposed infants, and the benefits observed from a nonhospital pilot treatment model that provided medical and nonmedical, nonpharmacologic care and wraparound supports. Section 2 directs the Health Care Authority (HCA) to study the feasibility and cost of providing facility-based payments to "residential pediatric recovery centers" as referenced in section 1007 of P.L. 115-271, to report those findings to appropriate legislative policy and fiscal committees by November 1, 2026, and to include specified items in the report (statutory or regulatory changes needed, IT changes and costs, elements for a federal waiver or state plan amendment, anticipated annual state cost with and without federal matching funds, and a proposed implementation timeline). Until the required report is submitted and subject to amounts appropriated for that purpose, the bill requires the HCA to provide grant funds to the facility that was the subject of the pilot project created in section 215(117), chapter 475, Laws of 2023 to ensure continued availability of services to infants with a history of substance exposure. The legislature states its intent to appropriate the grant funds from the opioid abatement settlement account. The study/report requirement and the interim grant authority expire on December 31, 2028. This proposal creates new law (two new sections) that establishes a procedural and fiscal study requirement and temporary grant authority; it does not create a new crime or change penalties. Affected parties include the HCA, the referenced pilot facility, residential pediatric recovery centers as referenced, infants with substance exposure and their parents/caregivers, and the legislative committees that will receive the report. Important details are missing from the text provided: "residential pediatric recovery centers" is not defined here, the specific pilot facility is not named, the exact legislative committees are not identified, the federal statutory provisions in section 1007 of P.L. 115-271 are not reproduced, and no appropriation amounts are specified.

If enacted, the health agency will be required to study and report by November 1, 2026 on what it would cost and what changes would be needed to pay residential pediatric recovery centers under federal rules, and while that study is pending the agency must use any appropriated money to keep the single pilot facility from the 2023 project operating so services for substance‑exposed infants remain available. Practically, this means that the pilot facility is likely to get temporary grant support (the legislature intends to use opioid abatement settlement funds), the agency will take on new planning, reporting, and potential IT and waiver work, and families of substance‑exposed infants could continue to access a nonhospital care model that the pilot showed can improve parental bonding and recovery and reduce long NICU stays and systemic costs. The main people and budgets affected are the pilot facility (short‑term funding stability), the Health Care Authority (new study and implementation tasks and associated costs), the state budget (possible new ongoing costs depending on whether federal matching funds are available), and infants and caregivers (continued access to the pilot model). Important details are missing here—exact definitions of these recovery centers, the identity of the pilot facility, and any specific appropriation amounts—so whether the temporary grants or any longer‑term program actually get funded or how broadly the model would expand is uncertain.